Head to Head Analysis: Intelligent Bio Solutions (NASDAQ:INBS) versus Inspire Medical Systems (NYSE:INSP)

Intelligent Bio Solutions (NASDAQ:INBS – Get Rating) and Inspire Medical Systems (NYSE:INSP – Get Rating) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, earnings, risk, institutional ownership, profitability and dividends.

Profitability

This table compares Intelligent Bio Solutions and Inspire Medical Systems’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Intelligent Bio Solutions	-687.95%	-85.52%	-46.54%
Inspire Medical Systems	-9.35%	-10.27%	-8.92%

Risk and Volatility

Intelligent Bio Solutions has a beta of 4.01, suggesting that its stock price is 301% more volatile than the S&P 500. Comparatively, Inspire Medical Systems has a beta of 1.44, suggesting that its stock price is 44% more volatile than the S&P 500.

Insider & Institutional Ownership

2.3% of Intelligent Bio Solutions shares are held by institutional investors. Comparatively, 97.0% of Inspire Medical Systems shares are held by institutional investors. 1.1% of Intelligent Bio Solutions shares are held by company insiders. Comparatively, 4.5% of Inspire Medical Systems shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Valuation & Earnings

This table compares Intelligent Bio Solutions and Inspire Medical Systems’ top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Intelligent Bio Solutions	$440,000.00	10.97	-$8.31 million	N/A	N/A
Inspire Medical Systems	$407.86 million	20.92	-$44.88 million	($1.56)	-188.65

Intelligent Bio Solutions has higher earnings, but lower revenue than Inspire Medical Systems.

Analyst Ratings

This is a breakdown of recent ratings and price targets for Intelligent Bio Solutions and Inspire Medical Systems, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Intelligent Bio Solutions	0	0	0	0	N/A
Inspire Medical Systems	0	0	8	0	3.00

Inspire Medical Systems has a consensus price target of $312.56, suggesting a potential upside of 6.21%. Given Inspire Medical Systems’ higher possible upside, analysts plainly believe Inspire Medical Systems is more favorable than Intelligent Bio Solutions.

Summary

Inspire Medical Systems beats Intelligent Bio Solutions on 9 of the 11 factors compared between the two stocks.

About Intelligent Bio Solutions

(Get Rating)

Intelligent Bio Solutions Inc., a life sciences company, developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. It offers Saliva Glucose Biosensor, an organic thin-film transistor for diabetes management that measures glucose in saliva. The company also focuses on developing SARS-CoV-2 Biosensor, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.

About Inspire Medical Systems

(Get Rating)

Inspire Medical Systems, Inc. engages in the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea. It offers inspire therapy, which consists of a remote control and implantable components that includes pressure sensing lead, a neurostimulator, and a stimulation lead. The company was founded by Timothy P. Herbert in November 2007 and is headquartered in Golden Valley, MN.